Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 131-159

  Holsapple, M P ^a   Karras, J G ^b   Ledbetter, J A ^c   Schieven, G L ^c   Burchiel, S W ^d   Davila, D R ^d   Schatz, A R ^e   Kaminski, N E ^f  

^a DOW CHEMICAL COMPANY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e ABBOTT LABORATORIES   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); cannabinoids; oxygen stress; polyaromatic hydrocarbons (PAHs)

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ADENYLATE CYCLASE; CALCIUM; CANNABINOID; CANNABINOID RECEPTOR; CHEMICAL AGENT; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN TYROSINE KINASE; TETRAHYDROCANNABINOL;

CALCIUM HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOTOXICITY; LYMPHOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029948666     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.36.040196.001023     Document Type: Review

References (112)

1. Fidelus RK, Ginouves P, Lawrence D, Tsan MF. 1987. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp. Cell. Res. 170:269-75
2. Kavanagh TJ, Grossmann A, Jinneman JC, Kanner SB, White CC, et al. 1993. The effect of 1-chloro-2,4-dinitrobenzene exposure on antigen receptor (CD3)-stimulated transmembrane signal transduction in purified subsets of human peripheral blood lymphocytes. Toxicol. Appl. Pharmacol. 119:91-99
3. Hamilos DL, Zelarney P, Mascali JJ. 1989. Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 18:223-35
4. El-Hag A, Lipsky PE, Bennett M, Clark RA. 1986. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions. J. Immunol. 136:3420-26
5. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, et al. 1994. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J. Immunol. 153: 4880-89
6. Fischman CM, Udey MC, Kurta M, Wedner HJ. 1981. Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence. J. Immunol. 127:2257-62
7. Freed BM, Lempert N, Lawrence DA. 1991. Inhibition of interleukin-2 production in the human T cell line JURKAT by nonpolar maleimides. Toxicol. Appl. Pharmacol. 107:173-82
8. Messina JP, Lawrence D. 1989. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol. 143:1974-81
9. Kavanagh TJ, Grossmann A, Jaecks EP, Jinneman JC, Eaton DL, et al. 1990. Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content. J. Cell. Physiol. 145:472-80
10. 2+. Toxicol. Appl. Pharmacol. 100: 485-97
11. 2+ signals. J. Biol. Chem. 268:16688-92
12. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM. 1993. Reactive oxygen intermediates activate NF-kB in a tyrosine kinase dependent mechanism and in combination with vanadate activate the p561ck and p59fyn tyrosine kinases in human lymphocytes. Blood 82:1212-20
13. 2 induced T cell signal transduction. J. Biol. Chem. 269:20718-26
14. Kanner SB, Kavanagh TJ, Grossmann A, Hu S-L, Bolen JB, et al. 1992. Sulfhydryl oxidation down-regulates T cell signaling and inhibits tyrosine phosphorylation of phospholipase C-gamma-1. Proc. Natl. Acad. Sci. USA 89:300-4
15. Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, et al. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264:1599-601
16. + thymic selection in humans lacking ZAP-70 kinase. Cell 76:947-58
17. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12:141-79
18. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, et al. 1994. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:22-29
19. Rushmore TH, Morton MR, Pickett CB. 1991. The antioxidant responsive element. J. Biol. Chem. 266:11632-39
20. Nishibe S, Wahl MI, Hernandez SSM, Tonks NK, Rhee SG, Carpenter G. 1990. Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. Science 250:1253-56
21. Secrist JP, Karnitz L, Abraham RT. 1991. T cell antigen receptor ligation induces tyrosine phosphorylation of phospholipase C-gamma1. J. Biol. Chem. 266:12135-39
22. Rabinovitch PS, June CH, Grossmann A, Ledbetter JA. 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137:952-61
23. Garcia-Morales P, Minami Y, Luong E, Klausner RD, Samelson LE. 1990. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc. Natl. Acad. Sci. USA 87:9255-59
24. Su XD, Taddei N, Stefani M, Ramponi G, Nordlund P. 1994. The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature 370:575-78
25. Fletcher MC, Samelson LE, June CH. 1993. Complex effects of phenylarsine oxide in T cells. Induction of tyrosine phosphorylation and calcium mobilization independent of CD45 expression. J. Biol. Chem. 268:23697-703
26. 2 and vanadate in vitro. Biochem. Biophys. Res. Commun. 188: 773-79
27. Ledbetter JA, Tonks NK, Fischer EH, Clark EA. 1988. CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc. Natl. Acad. Sci. USA 85:8628-32
28. Koretzky GA, Picus J, Schultz T, Weiss A. 1991. The tyrosine phosphatase CD45 is required for T cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA 88:2037-41
29. Justement LB, Campbell KS, Chien NC, Cambier JC. 1991. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 252: 1839-42
30. Sieh M, Bolen JB, Weiss A. 1993. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J. 12:315-21
31. Mustelin T, Pessa-Morikawa T, Autero M, Gassmann M, Andersson LC, et al. 1992. Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 22:1173-78
32. Cooper JA, Gould KL, Cartwright CA, Hunter T. 1986. Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science 231:1431-34
33. 2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142:4085-92
34. McConkey DJ, Hartzell P, Amador-Prez JF, Orrenius S, Jondal M. 1989. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/ T cell receptor complex. J. Immunol. 143:1801-6
35. Su X, Zhou T, Wang Z, Yang PA, Jope RS, Mountz JD. 1995. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2:353-62
36. Sato T, Irie S, Kitada S, Reed JC. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-15
37. Caelles C, Helmberg A, Karin M. 1994. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370:220-23
38. Mechoulam R. 1970. Marihuana chemistry. Science 168:1159-60
39. 9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 255:624-30
40. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-64
41. Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of peripheral receptor for cannabinoids. Nature 365:61-65
42. 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci. 51:25-30
43. Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR. 1992. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42: 736-42
44. Kaminski NE, Koh WS, Lee M, Yang KH, Kessler FK. 1994. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48:1899-908
45. Deleted in proof
46. 1. Proc. Natl. Acad. Sci. USA 83:6072-76
47. Maraguchi A, Miyazaki K, Fauci AS. 1984. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. J. Immunol. 133:1283-87
48. Smith JW, Steiner AL, Newberry WM, Parker CW. 1971. Cyclic adenosine 3′, 5′-monophosphate in human lymphocytes. Alteration after phytohemagglutinin. J. Clin. Invest. 50:432-41
49. Hadden JW, Hadden EM, Haddox MK, Goldberg ND. 1972. Guanosine 3′:5′-cyclic monophosphates: a possible intracellular mediator of mitogenic influences in lymphocytes. Proc. Natl. Acad. Sci. USA 69:3024-27
50. Russell DH. 1978. Type I cyclic AMP-dependent protein kinase as a positive effector of growth. Adv. Cyclic Nucleotide Res. 9:493-506
51. Cross ME, Ord MG. 1971. Changes in histone phosphorylation and associated early metabolic events in pig lymphocyte culture transformed by phytohaemagglutinin or 6-N,2′-O-dibutyryl-adenosine 3′:5′-cyclic monophosphate. Biochem. J. 124:241-48
52. Deleted in proof
53. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, et al. 1993. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214: 173-80
54. Lynn AB, Herkenham M. 1994. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268:1612-23
55. 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacol. 26:129-37
56. White KL, Kawabata TT, Ladics GS. 1994. Mechanisms of polycyclic aromatic hydrocarbon immunotoxicity. In Immunotoxicology and Immunopharmacology, ed. JH Dean, MI Luster, AE Munson, I Kimber. pp. 123-42. New York: Raven
57. 2+-associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbon. J. Toxicol. Environ. Health. 45: 101-26
58. Cambier JC, Pleiman CM, Clark MR. 1994. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:457-86
59. Weiss A, Littman DR. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-74
60. Burchiel SW, Thompson TA, Davis DP. 1991. Alterations in mitogen-induced calcium mobilization and intracellular free calcium produced by 7,12-dimethylbenz(a)anthracene (DMBA) in the Jurkat human T cell line. Int. J. Immunopharmacol. 13:109-15
61. Davis DP, Gomez MP, Barton SL, Montano RM, Burchiel SW. 1991. Suppression of local gut-associated immunity compared to splenic immunity following oral 7,12-dimethylbenz(a)anthracene ingestion in B6C3F1 mice. Fund. Appl. Toxicol. 17:429-31
62. Burchiel SW, Davis DP, Ray SD, Archuleta MM, Thilsted JP, Corcoran GB. 1992. DMBA-induced cytotoxicity in lymphoid and non-lymphoid organs of B6C3F1 mice. Relation of cell death to target cell intracellular calcium and DNA damage. Toxicol. Appl. Pharmacol. 113:126-32
63. Davis DP, Burchiel SW. 1992. Inhibition of calcium-dependent pathways of B cell activation by DMBA. Toxicol. Appl. Pharmacol. 116:202-8
64. Burchiel SW, Davis DP, Ray SD, Barton SL. 1993. DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fund. Appl. Toxicol. 21:120-24
65. Krieger JA, Born JL, Burchiel SW. 1994. Persistence of calcium elevation in the HPB-ALL human T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 127: 268-74
66. 3 formation, and mobilization of intracellular calcium. Proc. Natl Acad. Sci. USA 90: 6105-9
67. Clark GC, Blank JA, Germolec DR, Luster MI. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression. Mol. Pharmacol. 39:495-01
68. Krieger JA, Davila DR, Lytton JL, Born JL, Burchiel SW. 1995. Inhibition of sarcoplasmic/endoplasmic reticulum calcium-ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissues. Toxicol. Appl. Pharmacol. 133:102-8
69. Ward EC, Murray MJ, Dean JH. 1985. Immunotoxicity of nonhalogenated polycyclic aromatic hydrocarbons. In Immunotoxicology and Immunopharmacology, ed. JH Dean, MI Luster, AE Munson, H Amos. pp. 291-300. New York: Raven
70. Ladics GS, Kawabata TT, White KL. 1991. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz(a)-anthracene metabolites and inhibition of immunosuppression by α-napthoflavone. Toxicol. Appl. Pharmacol. 110: 31-44
71. Mudzinski SP. 1993. Effects of benzo(α)pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effects of parameters related to the G1 phase of the cell cycle. Toxicol. Appl. Pharmacol. 119: 166-74
72. Deleted in proof
73. Safe SH. 1986. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26:371-98
74. Whitlock JP. 1990. Genetic and molecular aspects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 30:251-77
75. Birnbaum LS. 1994. The mechanism of dioxin toxicity: relationship to risk assessment. Environ. Health Persp. 102 (Suppl. 9):157-67
76. Holsapple MP, Morris DL, Wood SC, Snyder NK. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms. Annu. Rev. Pharmacol. Toxicol. 31:73-100
77. Holsapple MP, Snyder NK, Wood SC, Morris DL. 1991. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 69:219-55
78. Holsapple MP. 1995. Immunotoxicity of halogenated aromatic hydrocarbons. In Experimental Immunotoxicology, ed. RJ Smialowicz, MP Holsapple, pp. 257-97. Boca Raton, FL: CRC
79. Holsapple MP, McNerney PJ, Dooley RK, McCay JA. 1986. Direct suppression of antibody responses by chlorinated dibenzodioxins in cultured spleen cells from (C57BL/6 × C3H) F1 and DBA/2 mice. Immunopharmacology 12: 175-86
80. Dooley RK, Holsapple MP. 1988. Elucidation of celluar targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of the antibody response. 1. Role of the B-lymphocyte. Immunopharmacology 16:167-80
81. Dooley RK, Morris DL, Holsapple MP. 1990. Elucidation of celluar targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of the antibody response. 2. Role of the T-lymphocyte. Immunopharmacology 19: 47-58
82. Luster MI, Germolec DR, Clark G, Wiegard G, Rosenthal GJ, et al. 1988. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140:928-35
83. Morris DL, Karras JG, Holsapple MP. 1993. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells. Immunopharmacology 26:105-12
84. Wood SC, Jeong HG, Morris DL, Holsapple MP. 1993. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes. Toxicology 81:131-43
85. Tucker AN, Vore SJ, Luster MI. 1986. Suppression of B cell differentation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 29:372-77
86. Dennis GJ, Mizuguchi J, McMillan V, Finkelman FD, Ohara J, et al. 1987. Comparison of the calcium requirement for the induction and maintenance of B-cell class II molecule expression and for B-cell proliferation stimulated by mitogens and purified growth factors. J. Immunol. 138:4307-312
87. Cambier JC, Ransom JT. 1987. Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu. Rev. Immunol. 5:175-91
88. DeFranco AL. 1987. Molecular aspects of B-lymphocyte activation. Annu. Rev. Cell Biol. 3:143-86
89. Chen ZZ, Coggeshall KM, Cambier JC. 1986. Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes. J. Immunol. 136:2300-11
90. Grupp SA, Snow EC, Harmony JAK. 1987. The phosphatidylinositol response is an early event in the physiologically relevant activation of antigen-specific B lymphocytes. Cell. Immunol. 109:181-87
91. Wilson HA, Greenblatt D, Poenie M, Finkelman FD, Tsien RY. 1987. Cross-linking of B lymphocyte surface immunoglobulin by anti-Ig or antigen induces prolonged oscillation of intracellular ionized calcium. J. Exp. Med. 166:601-14
92. Puga A, Nebert DW, Carrier F. 1992. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell. Biol. 11:269-83
93. Al-Bayati ZAF, Murray WJ, Pankaskie MC, Stohs, SJ. 1988. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced perturbation of calcium distribution in the rat. Res. Commun. Chem. Pathol. Pharmacol. 60(1):45-61
94. Canga L, Levi R, Rifkind AB. 1988. Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA 85:905-21
95. Karras JG, Holsapple MP. 1994. Mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced disruption of B-lympbocyte signaling in the mouse: a current perspective. Exp. Clin. Immunogenet. 11:110-18
96. Rothstein TL, Baeker TR, Miller RA, Kolber DL. 1986. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester. Cell. Immunol. 102:364-82
97. Klaus GGB, O'Garra A, Bijsterbosch MK, Holman M. 1986. Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate. Eur. J. Immunol. 16:92-103
98. Karras JG, Holsapple MP. 1994. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 125: 264-70
99. Kramer CM, Johnson KW, Dooley RK, Holsapple MP. 1987. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on kinase activation and background antibody production in murine B-cells. Biochem. Biophys. Res. Commun. 145: 25-33
100. Freedman MH. 1979. Early biochemical events in lymphocyte activation. I. Investigations on the nature and significance of early calcium fluxes observed in mitogen-induced T- and B-lymphocytes. Cell. Immunol. 44:290-307
101. Wood SC, Karras JG, Holsapple MP. 1992. Integration of the human lymphocyte into immunotoxicological investigations. Fundam. Appl. Toxicol. 18: 450-59
102. Fauci AS, Whalen G, Burch C. 1980. Activation of human B lymphocytes. XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total immunoglobulin producing plaque forming cells in peripheral blood. Cell. Immunol. 54:230-40
103. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. 1992. A 39 kDa protein on activated helper T-cells binds CD40 and transduces the signal for cognate activation of B-cells. Proc. Natl. Acad. Sci. USA 89:6550-64
104. Bartlett WC, McCann J, Shepherd DM, Roy M, Noelle, RJ. 1990. Cognate interactions between helper T-cells and B-cells. IV. Requirements for the expression of effector phase activity by helper T-cells. J. Immunol. 145:3956-68
105. Karras JG, Morris DL, Matulka RA, Kramer CL, Holsapple MP. 1995. 2,3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion. Toxicol. Appl. Pharmacol. In press
106. Yellen AJ, Glenn W, Sukhatme VP, Cao X, Monroe JG. 1991. Signaling through surface IgM in tolerance-susceptible immature murine B-lymphocytes. Developmentally regulated differerences in transmembrane signaling in splenic B-cells from adult and neonatal mice. J. Immunol. 146:1446-54
107. 2+-ATPase. Proc. Natl. Acad. Sci. USA 87:2466-78
108. 2+-mediated endonuclease activation. Science 242: 256-59
109. Silverstone AJ, Frazier DE, Fiore NC, Soults JA, Gasiewicz TA. 1994. Dexamethasone, beta-estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 126: 248-59
110. Ennan E, Matsumura F. 1995. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49: 249-61
111. Casillas A, Hanekom C, Williams K, Katz R, Nel AE. 1991. Stimulation of B-cells via the membrane immunoglobulin receptor or with phorbol myristate 13-acetate induces tyrosine phosphorylation and activation of a 42 kD microtubule-associated protein-2 kinase. J. Biol. Chem. 266(28):19088-99
112. Gold MR, Law DA, DeFranco AL. 1990. Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor. Nature 345:810-14